DCIS | Breast Carcinoma TNM Breast tumor staging
Item
history of non-metastatic breast cancer (dcis or stage i, ii, or iii) as recorded in the medical record at mskcc by self-report, or by outside correspondence, including a study checklist signed by a physician for patients outside of mskcc
boolean
C0007124 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
Status post Cancer treatment Completion | Hormone Therapy | Tamoxifen | Herceptin
Item
>3 months post completion of treatment (may be on hormone therapy, such as tamoxifen or, herceptin) for any type of cancer as confirmed by the medical record at mskcc, by self-report, or by outside correspondence, including a study checklist signed by a physician for patients outside of mskcc
boolean
C0231290 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2])
C0039286 (UMLS CUI [3])
C0338204 (UMLS CUI [4])
Age
Item
age 18 or older
boolean
C0001779 (UMLS CUI [1])
Access to telephone | Access Computer | Access Internet
Item
access to a telephone, computer, and internet
boolean
C1822200 (UMLS CUI [1])
C0444454 (UMLS CUI [2,1])
C0009622 (UMLS CUI [2,2])
C0444454 (UMLS CUI [3,1])
C0282111 (UMLS CUI [3,2])
Trial Phase Number
Item
for phase 2 only:
boolean
C1710475 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Distress Thermometer | Distress Relationship Breast Carcinoma | Distress Relationship Survivorship
Item
a score of > or = to 4 on the distress thermometer (dt) and indication that this distress is related in some way to the patient's breast cancer or survivorship
boolean
C4321507 (UMLS CUI [1])
C0231303 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C0231303 (UMLS CUI [3,1])
C0439849 (UMLS CUI [3,2])
C0038955 (UMLS CUI [3,3])
Mood Stabilizer | Anti-Anxiety Agents | Antidepressive Agents | Pharmaceutical Preparations Thoughts | Pharmaceutical Preparations Hallucinations | Sleep Disorder Agents | Change Clinical Significance Lacking
Item
if taking medication for mood, anxiety, depression, thoughts, sensory experiences such as hallucinations, or sleep, stable and consistent enough in dosage and use of that medication so as to not result in a clinically significant change as determined by the study pi/co-pi or, confirmed by reports in the medical record at mskcc, by selfreport, or by outside correspondence, including a study checklist signed by a physician for patients outside of mskcc
boolean
C2917435 (UMLS CUI [1])
C0040616 (UMLS CUI [2])
C0003289 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C4319827 (UMLS CUI [4,2])
C0013227 (UMLS CUI [5,1])
C0018524 (UMLS CUI [5,2])
C4020625 (UMLS CUI [6])
C0392747 (UMLS CUI [7,1])
C2826293 (UMLS CUI [7,2])
C0332268 (UMLS CUI [7,3])
Participation Absent Trial Phase Number
Item
did not participate in phase 1
boolean
C0679823 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1710475 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,4])
Neoplasm Metastasis | Therapeutic procedure Neoplasm Metastasis
Item
evidence of or treatment metastatic disease
boolean
C0027627 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
Mental disorder Excludes Informed Consent | Impaired cognition Excludes Informed Consent | Mental disorder Excludes Participation Groups | Impaired cognition Excludes Participation Groups | Psychiatric symptom Requirement Individual psychiatric therapy
Item
significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent or participating in the groups (i.e., acute psychiatric symptoms which require individual treatment).
boolean
C0004936 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C0338656 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
C0004936 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0679823 (UMLS CUI [3,3])
C0441833 (UMLS CUI [3,4])
C0338656 (UMLS CUI [4,1])
C0332196 (UMLS CUI [4,2])
C0679823 (UMLS CUI [4,3])
C0441833 (UMLS CUI [4,4])
C0233401 (UMLS CUI [5,1])
C1514873 (UMLS CUI [5,2])
C2048936 (UMLS CUI [5,3])